Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)
/ Chongqing Zhifei
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
May 13, 2024
Omicron BA.4/5-Delta Strain Recombinant Novel Coronavirus Protein Vaccine (CHO Cells)
(clinicaltrials.gov)
- P=N/A | N=450 | Completed | Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | Active, not recruiting ➔ Completed | Trial completion date: Nov 2023 ➔ Mar 2024
Trial completion • Trial completion date • Infectious Disease • Novel Coronavirus Disease
September 21, 2023
Omicron BA.4/5-Delta COVID-19 Vaccine Phase I Clinical Trial
(clinicaltrials.gov)
- P1 | N=100 | Not yet recruiting | Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
New P1 trial • Infectious Disease • Novel Coronavirus Disease
1 to 2
Of
2
Go to page
1